Sycamore Partners has acquired Walgreens Boots Alliance for $23.7 billion in a deal aimed at revitalizing the struggling retail pharmacy chain.
Overview of the Deal
In a significant transaction valued at $23.7 billion, Sycamore Partners, a U.S.-based private equity firm, has completed the acquisition of Walgreens Boots Alliance (WBA), one of the world’s largest retail pharmacy and health companies. With a global presence exceeding 12,500 locations, this acquisition marks a pivotal moment for Sycamore as it aims to take WBA private after years on the public market. The firm is optimistic about leading a financial turnaround for WBA, which has seen its market value drastically decline from a peak of $100 billion in 2014 to less than $10 billion.
The decline in WBA’s market value can be attributed to several factors, including escalating competition from e-commerce and the financial burdens stemming from its costly expansion into healthcare services. By transitioning to private ownership, WBA, in partnership with Sycamore, seeks increased agility and the ability to implement necessary changes without the constraints of public market expectations.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the United States
The retail pharmacy and healthcare industry in the United States plays a vital role in the nation’s healthcare system and consumer market. With a market size exceeding $350 billion, it comprises various segments, including prescription drugs, over-the-counter m
Similar Deals
Hiltz Capital Management → Crestline Bagel Company
2025
North Grounds Partners → Royal Cleaners
2025
Service Country → Childress Heating & Cooling
2025
Northleaf Capital Partners and AVALT → WASH Multifamily Holdings Inc
2025
Sycamore Partners
invested in
Walgreens Boots Alliance (WBA)
in 2025
in a Buyout deal
Disclosed details
Transaction Size: $23,700M
Revenue: $151,950M
EBITDA: $1,420M
Enterprise Value: $38,830M
Equity Value: $9,820M
Multiples
EV/EBITDA: 27.3x
EV/Revenue: 0.3x
P/Revenue: 0.1x